molecular function |
| GO:0070700 | | BMP receptor binding | | Interacting selectively and non-covalently with a BMP receptor. |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0008201 | | heparin binding | | Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005160 | | transforming growth factor beta receptor binding | | Interacting selectively and non-covalently with the transforming growth factor beta receptor. |
biological process |
| GO:0030509 | | BMP signaling pathway | | A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0060395 | | SMAD protein signal transduction | | The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. |
| GO:0048646 | | anatomical structure formation involved in morphogenesis | | The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. |
| GO:0009887 | | animal organ morphogenesis | | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| GO:0007411 | | axon guidance | | The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. |
| GO:0060445 | | branching involved in salivary gland morphogenesis | | The process in which the branching structure of the salivary gland is generated and organized. |
| GO:0048754 | | branching morphogenesis of an epithelial tube | | The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder. |
| GO:0048593 | | camera-type eye morphogenesis | | The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field. |
| GO:0051216 | | cartilage development | | The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
| GO:0048468 | | cell development | | The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
| GO:0030154 | | cell differentiation | | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| GO:0071773 | | cellular response to BMP stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus. |
| GO:0071456 | | cellular response to hypoxia | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| GO:0016358 | | dendrite development | | The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure. A dendrite is a freely branching protoplasmic process of a nerve cell. |
| GO:0048596 | | embryonic camera-type eye morphogenesis | | The process in which the anatomical structures of the eye are generated and organized during embryonic development. |
| GO:0030326 | | embryonic limb morphogenesis | | The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. |
| GO:0009880 | | embryonic pattern specification | | The process that results in the patterns of cell differentiation that will arise in an embryo. |
| GO:0060272 | | embryonic skeletal joint morphogenesis | | The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton. |
| GO:0030855 | | epithelial cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. |
| GO:0001837 | | epithelial to mesenchymal transition | | A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| GO:0001654 | | eye development | | The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. |
| GO:0040007 | | growth | | The increase in size or mass of an entire organism, a part of an organism or a cell. |
| GO:0001822 | | kidney development | | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| GO:0048762 | | mesenchymal cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types. |
| GO:0060485 | | mesenchyme development | | The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells. |
| GO:0001707 | | mesoderm formation | | The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts. |
| GO:0001823 | | mesonephros development | | The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney. |
| GO:0072136 | | metanephric mesenchymal cell proliferation involved in metanephros development | | The multiplication or reproduction of cells, resulting in the expansion of a metanephric mesenchymal cell population. |
| GO:0072133 | | metanephric mesenchyme morphogenesis | | The process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros. |
| GO:0001656 | | metanephros development | | The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine. |
| GO:0070487 | | monocyte aggregation | | The adhesion of one monocyte to one or more other monocytes via adhesion molecules. |
| GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| GO:0043407 | | negative regulation of MAP kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. |
| GO:0042347 | | negative regulation of NF-kappaB import into nucleus | | Any process that stops, prevents, or reduces the frequency, rate or extent of the transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane. |
| GO:0032088 | | negative regulation of NF-kappaB transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| GO:0045746 | | negative regulation of Notch signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway. |
| GO:0045786 | | negative regulation of cell cycle | | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| GO:0060548 | | negative regulation of cell death | | Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| GO:0072125 | | negative regulation of glomerular mesangial cell proliferation | | Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation. |
| GO:0072040 | | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | | Any process that reduces the occurrence or rate of mesenchymal stem cell death by apoptotic process that contributes to the shaping of the nephron. |
| GO:0045839 | | negative regulation of mitotic nuclear division | | Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother. |
| GO:0050768 | | negative regulation of neurogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons. |
| GO:0045665 | | negative regulation of neuron differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation. |
| GO:0042326 | | negative regulation of phosphorylation | | Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. |
| GO:0060686 | | negative regulation of prostatic bud formation | | Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth. |
| GO:0010664 | | negative regulation of striated muscle cell apoptotic process | | Any process that decreases the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0072134 | | nephrogenic mesenchyme morphogenesis | | The process in which the anatomical structures of a nephrogenic mesenchymal tissue are generated and organized. Nephrogenic mesenchyme is the tissue made up of loosely connected mesenchymal cells in the nephron. |
| GO:0048812 | | neuron projection morphogenesis | | The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites. |
| GO:0042475 | | odontogenesis of dentin-containing tooth | | The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel. |
| GO:0001503 | | ossification | | The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
| GO:0007389 | | pattern specification process | | Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0030501 | | positive regulation of bone mineralization | | Any process that activates or increases the frequency, rate or extent of bone mineralization. |
| GO:0010942 | | positive regulation of cell death | | Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:0045597 | | positive regulation of cell differentiation | | Any process that activates or increases the frequency, rate or extent of cell differentiation. |
| GO:1900006 | | positive regulation of dendrite development | | Any process that activates or increases the frequency, rate or extent of dendrite development. |
| GO:0034116 | | positive regulation of heterotypic cell-cell adhesion | | Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion. |
| GO:1900106 | | positive regulation of hyaluranon cable assembly | | Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly. |
| GO:0045666 | | positive regulation of neuron differentiation | | Any process that activates or increases the frequency, rate or extent of neuron differentiation. |
| GO:0045669 | | positive regulation of osteoblast differentiation | | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
| GO:0010862 | | positive regulation of pathway-restricted SMAD protein phosphorylation | | Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
| GO:0010800 | | positive regulation of peptidyl-threonine phosphorylation | | Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0034504 | | protein localization to nucleus | | A process in which a protein transports or maintains the localization of another protein to the nucleus. |
| GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| GO:0060687 | | regulation of branching involved in prostate gland morphogenesis | | Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem. |
| GO:0060393 | | regulation of pathway-restricted SMAD protein phosphorylation | | Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
| GO:0042325 | | regulation of phosphorylation | | Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. |
| GO:2000121 | | regulation of removal of superoxide radicals | | Any process that modulates the frequency, rate or extent of removal of superoxide radicals. |
| GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0043434 | | response to peptide hormone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. |
| GO:0033280 | | response to vitamin D | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. |
| GO:0007435 | | salivary gland morphogenesis | | The process in which the anatomical structures of the salivary gland are generated and organized. |
| GO:0001501 | | skeletal system development | | The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
| GO:0043401 | | steroid hormone mediated signaling pathway | | A series of molecular signals mediated by a steroid hormone binding to a receptor. |
| GO:0035239 | | tube morphogenesis | | The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system. |
| GO:0001657 | | ureteric bud development | | The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure. |
cellular component |
| GO:0031012 | | extracellular matrix | | A structure lying external to one or more cells, which provides structural support for cells or tissues. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |